Design, synthesis and molecular modelling studies of novel 3-acetamido-4-methyl benzoic acid derivatives as inhibitors of protein tyrosine phosphatase 1B

Monika Rakse, Chandrabose Karthikeyan, Girdhar Singh Deora, N S H N Moorthy, Vandana Rathore, Arun K. Rawat, A. K. Srivastava, Piyush Trivedi

Research output: Contribution to journalArticleResearchpeer-review

20 Citations (Scopus)


A novel series of 3-acetamido-4-methyl benzoic acid derivatives designed on the basis of vHTS hit ZINC02765569 were synthesized and screened for PTP1B inhibitory activity. The most potent compounds 3-(1-(5-methoxy-1H-benzo[d] imidazol-2-ylthio)acetamido)-4-methyl benzoic acid (10c, IC50 8.2 μM) and 3-(2-(benzo[d]thiazol-2-ylthio)acetamido)-4-methyl benzoic acid (10e, IC50 8.3 μM) showed maximum PTP1B inhibitory activity. Docking studies were also performed to understand the nature of interactions governing the binding mode of the designed molecules within the active site of the PTP1B enzyme. 

Original languageEnglish
Pages (from-to)469-476
Number of pages8
JournalEuropean Journal of Medicinal Chemistry
Publication statusPublished - 2013
Externally publishedYes


  • Acetamido benzoic acid derivatives
  • Diabetes
  • Lead optimization
  • Molecular modelling
  • PTP1B

Cite this